Bio-Techne Corporation today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:45 a.m. EDT.
ESMO 2023: MSD’s Welireg leads HIF-2α inhibitors in RCC despite unclear OS – Pharmaceutical Technology
Welireg was reported to have a well-tolerated safety profile similar to that of Afinitor while having a longer time to function deterioration for better patient